https://www.selleckchem.com/products/AZD0530.html
Baseline scores were similar between the groups. After treatment, there were no statistically significant differences in the function scales, including body image, ****ual functioning, and ****ual enjoyment between the groups, although the endocrine treatment group showed a significant improvement in the future perspective (hazard ratio, 8.3; 95% confidence interval, 1.72-18.38; P = 0.021). Similarly, there were no statistically significant differences in the symptom scales between the groups, including adverse effects of systemic therapy